Presentation is loading. Please wait.

Presentation is loading. Please wait.

AFACT Trial design: Patients with long-standing atrial fibrillation were randomized to ganglion plexus ablation (n = 117) vs. control (n = 123) on top.

Similar presentations


Presentation on theme: "AFACT Trial design: Patients with long-standing atrial fibrillation were randomized to ganglion plexus ablation (n = 117) vs. control (n = 123) on top."— Presentation transcript:

1 AFACT Trial design: Patients with long-standing atrial fibrillation were randomized to ganglion plexus ablation (n = 117) vs. control (n = 123) on top of pulmonary vein isolation and additional left atrial lines via thoracoscopy. Results (p = 0.70) No atrial fibrillation recurrences: 70.9% of the ganglion plexus group vs. 68.4% of the control group (p = 0.70) Total procedure-related adverse events: 19% in the ganglion plexus group vs. 8% in the control group (p = 0.022) Bleeding: 8% in the ganglion plexus group vs. 0 in the control group (p = 0.001) 70.9 68.4 % Conclusions Among patients with long-standing atrial fibrillation, ganglion plexus block was unsuccessful at achieving a higher frequency of freedom from atrial fibrillation in addition to pulmonary vein isolation Ganglion plexus block Control Driessen AH, et al. J Am Coll Cardiol 2016;68:


Download ppt "AFACT Trial design: Patients with long-standing atrial fibrillation were randomized to ganglion plexus ablation (n = 117) vs. control (n = 123) on top."

Similar presentations


Ads by Google